For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating-and possibly even ...

A total of 10 individuals with HIV have been cured to date. Most of these patients have remained anonymous, but three have ...

Lenacapavir has delivered impressive trial results and, in July, it received official backing from the World Health ...

A recent study by the German Center for Infection Research reveals how HIV integrates its genetic material into human DNA, potentially leading to new treatment strategies.

Gilead has agreed to provide the drug at cost and to share its intellectual property with generic manufacturers who can ...

Uganda is set to introduce a new long-acting HIV prevention drug, Lenacapavir, in 2026 under a United States-funded ...

The discovery of broadly neutralizing antibodies (bNAbs) like b12 in 1994 marked a turning point in HIV research. B12 demonstrated potent virus-neutralizing ability by targeting a difficult-to-reach ...

Lenacapavir has the potential to end the HIV epidemic, researchers say. The Trump administration says backing this kind of ...

A groundbreaking deal will make a new HIV prevention drug affordable in over 100 low-income countries, potentially advancing ...

For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even ...

Wes Sundquist wasn't trying to become one of TIME's 100 most influential people in the world. He wasn't shooting for Science ...